title: HIV-related liver disease: ARV drugs, coinfection, and other risk factors.
abstract: Highly-active antiretroviral therapy (HAART) has proven remarkably effective for prolonging the life of patients with human immunodeficiency virus (HIV). However, while most HAART agents are safe, many have the potential to cause liver toxicity. Physicians must therefore consider the possibility of drug-induced liver injury in the management of HIV-infected patients, especially those with certain risk factors such as coinfection with hepatitis B virus (HBV) or hepatitis C virus (HCV), female gender, alcohol abuse, older age, or obesity. Understanding how, when, and why drug-related liver damage occurs is key to managing these patients safely and effectively. Knowledge of HAART-related liver effects will help ensure that patients receive the most benefit with the least toxicity from any given drug regimen. As more information about the mechanisms of drug related liver injury is known, clinicians will be better able to tailor therapies to suit individual situations, resulting in greater patient safety and outcomes.
authors.affiliation: Department of Infectious and Tropical Diseases, University of Brescia, AO Spedali Civili, Brescia, Italy. massimopuoti@libero.it
authors.forename: Massimo
authors.initials: M
authors.lastname: Puoti
authors.forename: Paola
authors.initials: P
authors.lastname: Nasta
authors.forename: Francesca
authors.initials: F
authors.lastname: Gatti
authors.forename: Alessandro
authors.initials: A
authors.lastname: Matti
authors.forename: Katiela
authors.initials: K
authors.lastname: Prestini
authors.forename: Luciano
authors.initials: L
authors.lastname: Biasi
authors.forename: Giampiero
authors.initials: G
authors.lastname: Carosi
mesh_terms: D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications; D006526:Hepatitis C / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D015995:Prevalence; D012307:Risk Factors
chemical_list: D019380:Anti-HIV Agents